Benefits of Outsourced Medical Writing
As business increases, medical device and pharmaceutical companies are finding success turning to outside vendors to meet their technical and regulatory writing needs. In doing so, these organizations gain real […]
What the FDA Reauthorization Act Means for Pharmaceuticals and Medical Devices
On August 18th, President Trump signed the FDA Reauthorization Act (FDARA). Besides reauthorizing user fees for pharmaceuticals and medical devices for five years the law also focuses on many aspects […]